柠檬酸托米芬

柠檬酸托米芬（CAS 89778-27-8）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.

同义词与商品名

TOREMIFENE CITRATE; 89778-27-8; DTXSID2021367; FC 1157a; FC-1157a; NSC-613680; NSC613680; 2498Y783QT; DTXCID301367; Citrate, Toremifene; RefChem:57434; Toremifene Citrate (1:1); FC1157a; 2-(p-((Z)-4-chloro-1,2-diphenyl-1-butenyl)-phenoxy)-N,N-dimethylethylamine citrate (1:1); Fareston; Toremifene citrate [USAN]

GHS 危害分类

Reported hazard statements	H302 (97.6%), H318 (92.7%), H400 (92.7%), H410 (92.7%)

H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]

H318 (92.7%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

公开数据库对它的描述

TOREMIFENE CITRATE · CAS 89778-27-8 · C32H36ClNO8. UNII 2498Y783QT.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。